AI Bio 소식
[BOC Science 대리점 에이아이바이오허브]Cyclophosphamide(50-18-0 )
- AI바이오허브 오래 전 2025.08.26 22:14 제품소개 인기
-
105
0
Cyclophosphamide
Catalog NO.: 50-18-0
CAS NO.: 50-18-0
Brand: BOC Sciences
CategoryInhibitor:Tag/TargetsDNA Alkylator/Crosslinker Others (Nonspecific immune stimulation)
Molecular FormulaC7H15Cl2N2O2P:Molecular Weight261.09
Product Description:Low-dose preferentially deplets Treg cells; An alkylating agent of the nitrogen mustard type with antineoplastic and immunosuppressive activities; Phase I-II
Related CAS:6055-19-2 (hydrate) 50-18-0 (anhydrous)
Appearance:Fine White lyophilised solid
Synonyms:Cytoxan; Clafen; Neosar; CTX; 2-Bis(2-chloroethyl)aminotetrahydro-2H-1,3,2-oxazophosphorine-2-oxide; N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
Solubility:In water, 1-5 g/100 mL at 23 °C; slightly soluble in benzene, carbon tetrachloride; very slightly soluble in ether and acetone.
Storage:Stored at room temp or within 6 days if stored under refrigeration. When constituted with sterile water for injection or paraben-preserved bacteriostatic water for injection to a concn of 21 mg/ml, <1.5% cyclophosphamide decomposition will occur within 8
Quality: StandardIn-house
PROPERTIES
Quantity:Grams-Kilos
Boiling Point:336
Melting Point:41-45°C
Density:1.3±0.1 g/cm3
InChI Key:CMSMOCZEIVJLDB-UHFFFAOYSA-N
InChI:InChI=1S/C7H15Cl2N2O2P/c8-2-5-11(6-3-9)14(12)10-4-1-7-13-14/h1-7H2,(H,10,12)
SMILES:C1CNP(=O)(OC1)N(CCCl)CCCl
REFERENCES
1.Control of nausea with palonosetron versus granisetron, both combined with dexamethasone, in patients receiving cisplatin- or anthracycline plus cyclophosphamide-based regimens.
Kubota K1, Saito M2, Aogi K3, Sekine I4, Yoshizawa H5, Yanagita Y6, Sakai H7, Inoue K8, Kitagawa C9, Ogura T10. Support Care Cancer. 2016 Apr 29. [Epub ahead of print]
PURPOSE: In a comparative phase 3 study involving 1114 Japanese patients receiving highly emetogenic chemotherapy (HEC), palonosetron (PALO) was found to be superior to granisetron (GRA) for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV) in the delayed phase. This post hoc analysis of the phase 3 study evaluated the efficacy of PALO for the control of nausea.
견적 문의: aibiohub@aibiohub.co.kr 홈페이지: www.aibiohub.co.kr
견적 문의: https://aibiohub.co.kr/estimate/write
- 이전글[Amid Bioscience 대리점 에이아이바이오허브]Phage Display SS320 Chemically Competent E. coli Cells(SS320-201)2025.08.26
- 다음글[Biosynth 대리점 에이아이바이오허브]Amoscanate(AA183407)2025.08.26
댓글목록
등록된 댓글이 없습니다.

